Virological response and resistance profile in virologically suppressed HIV-1 infected individuals switching to a bictegravir based treatment in clinical practice

被引：0
|
作者：
Armenia, D. [1 ]
Forbici, F. [2 ]
Bertoli, A. [3 ]
Berno, G. [2 ]
Malagnino, V. [4 ]
Gagliardini, R. [2 ]
Borghi, V. [5 ]
Gennari, W. [5 ]
Cicalini, S. [2 ]
Buonomini, A. [6 ]
Teti, E. [4 ]
Latini, A. [6 ]
Sarmati, L. [4 ]
Mussini, C. [5 ]
Andreoni, M. [4 ]
Antinori, A. [2 ]
Perno, C. F. [7 ]
Ceccherini-Silberstein, F. [3 ]
Santoro, M. M. [3 ]
机构：
[1] St Camillus Int Univ Hlth Sci, Rome, Italy
[2] IRCCS, Natl Inst Infect Dis L Spallanzani, Rome, Italy
[3] Univ Roma Tor Vergata, Rome, Italy
[4] Polyclin Rome Tor Vergata, Rome, Italy
[5] Polyclin Modena, Modena, Italy
[6] IRCCS, San Gallicano Dermatol Inst, Rome, Italy
[7] Bambino Gesu Pediat Hosp, Rome, Italy
来源：
HIV MEDICINE | 2021年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
BPD1/2
引用
收藏
页码：26 / 28
页数：3
相关论文
共 50 条
  • [41] Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial
    Kityo, Cissy
    Hagins, Debbie
    Koenig, Ellen
    Avihingsanon, Anchalee
    Chetchotisakd, Ploenchan
    Supparatpinyo, Khuanchai
    Gankina, Natalya
    Pokrovsky, Vadim
    Voronin, Evgeny
    Stephens, Jeffrey L.
    DeJesus, Edwin
    Wang, Hui
    Acosta, Rima K.
    Cao, Huyen
    Quirk, Erin
    Martin, Hal
    Makadzange, Tariro
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 82 (03) : 321 - 328
  • [42] Switching to emtricitabine, tenofovir and rilpivirine as single tablet regimen in virologically suppressed HIV-1-infected patients: a cohort study
    Gantner, P.
    Reinhart, S.
    Partisani, M.
    Baldeyrou, M.
    Batard, M-L
    Bernard-Henry, C.
    Cheneau, C.
    de Mautort, E.
    Priester, M.
    Fafi-Kremer, S.
    Muret, P.
    Rey, D.
    HIV MEDICINE, 2015, 16 (02) : 132 - 136
  • [43] HIV-1 Subtype and Virological Response to Antiretroviral Therapy: Acquired Drug Resistance
    Soares, Esmeralda A.
    Santos, Andre F.
    Soares, Marcelo A.
    CLINICAL INFECTIOUS DISEASES, 2012, 54 (05) : 738 - 738
  • [44] Metabolic changes at 48 weeks in virologically suppressed people with HIV switching from complex antiretroviral regimens to bictegravir plus lenacapavir: ARTISTRY-1 trial
    Prelutsky, David
    Mounzer, Karam
    Ramgopal, Moti
    Slim, Jihad
    Hedgcock, Malcolm
    Segal-Maurer, Sorana
    Bloch, Mark
    Zhang, Xu
    Montezuma-Rusca, Jairo M.
    Sklar, Peter
    Ruane, Peter
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 59 - 60
  • [45] Factors influencing antiretroviral therapy switching in people with virologically suppressed HIV-1: a cross-sectional multicenter study in France
    Pourcher, Valerie
    Robineau, Olivier
    Parienti, Jean-Jacques
    Loubet, Paul
    Palacios, Christia
    Jacomet, Christine
    Benachir, Haydar
    Mariot, Philippe
    Spire, Bruno
    Slama, Laurence
    AIDS, 2025, 39 (06) : 695 - 700
  • [46] Switch from enfuvirtide to raltegravir in virologically suppressed HIV-1 infected patients: Effects on level of residual viremia and quality of life
    Grant, Philip M.
    Palmer, Sarah
    Bendavid, Eran
    Talbot, Annie
    Slamowitz, Debbie C.
    Cain, Pat
    Kobayashi, Stacy S.
    Balamane, Maya
    Zolopa, Andrew R.
    JOURNAL OF CLINICAL VIROLOGY, 2009, 46 (04) : 305 - 308
  • [47] Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice
    Potard, Valerie
    Reynes, Jacques
    Ferry, Tristan
    Aubin, Celine
    Finkielsztejn, Laurent
    Yazdanpanah, Yazdan
    Costagliola, Dominique
    PLOS ONE, 2015, 10 (12):
  • [48] Characterization of the HIV-1 transcription profile after romidepsin administration in ART-suppressed individuals
    Moron-Lopez, Sara
    Kim, Peggy
    Sogaard, Ole S.
    Tolstrup, Martin
    Wong, Joseph K.
    Yukl, Steven A.
    AIDS, 2019, 33 (03) : 425 - 431
  • [49] Comparison of the performance of genotype-based HIV-1 resistance analysis systems to predict virological response
    Winters, B
    Van der Borght, K
    Bacheler, L
    ANTIVIRAL THERAPY, 2005, 10 : S61 - S61
  • [50] Comparison of the performance of genotype-based HIV-1 resistance analysis systems to predict virological response
    Winters, B
    Van Der Borght, K
    Bacheler, L
    ANTIVIRAL THERAPY, 2005, 10 (04) : S61 - S61
12345